Industrials
Markolines Pavement Technologies Limited Q4fy26 Earnings Update: PAT Up 15%, Revenue Grows 4%
Markolines Pavement Technologies Limited (MARKOLINES) reports Q4FY26 earnings with a 15% PAT growth and 4% revenue increase, driven by operational efficiencies.
Markolines Pavement Technologies Limited (MARKOLINES) announced its unaudited financial results for the quarter ended June 30, 2026, showcasing a robust performance. The company reported a 15.06% year-on-year growth in PAT and a 4.33% increase in revenue from operations, reaching Rs. 75.86 crore. These results were driven by operational efficiencies and a strong focus on technology-led solutions.
Financial Highlights
The consolidated EBITDA for the quarter stood at Rs. 9.18 crore, marking an 8.68% year-on-year increase. The PAT for Q1FY27 was Rs. 4.36 crore, reflecting a significant 15.06% growth compared to the same period last year. The operational efficiencies contributed to a 49 basis points expansion in the EBITDA margin on a year-on-year basis.
Key Developments
Markolines remains optimistic about its diversified growth strategy. The company’s unexecuted order book stands robust at Rs. 550+ crore, providing visibility for the next 18 months. Additionally, Markolines is progressing with the amalgamation of its group company, Markolines Infra Limited, and is evaluating opportunities in the Marine Infrastructure Construction & Maintenance segment.
As the company continues to leverage its engineering expertise and specialized skill set, it aims to create sustainable long-term value and capitalize on India’s infrastructure growth story. With a strong project pipeline and disciplined cost management, Markolines is well-positioned to sustain its growth momentum.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Markolines Pavement Technologies Limited
Markolines Pavement Technologies Limited belongs to the Industrials › Infrastructure Operations sector. Here’s a quick read on where the business and the stock stand today.
Markolines holds in the upper half of its 52-week range, a sign the market backs the stock. The PEG of 0.79 signals undervaluation relative to growth. It is a potential re-rating candidate. Thin margins at 7.5% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock trades at 72% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. Revenue grows at 9.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Markolines Pavement Technologies Limited.
GESHIP
The Great Eastern Shipping Company Limited (geship) Contracts to Buy a New-building Suezmax Tanker
The Great Eastern Shipping Company Limited (GESHIP) announces a contract to acquire a new-building Suezmax Tanker, expanding its fleet and enhancing capacity.
The Great Eastern Shipping Company Limited (GESHIP) has entered into a contract to acquire a new-building Suezmax Tanker of about 157,000 dwt on 28th September 2026. The vessel will be constructed in the Far East by one of the world’s leading shipbuilders. The purpose of the acquisition is to expand the company’s fleet. Currently, GESHIP’s owned fleet comprises 40 vessels, including 25 Tankers and 15 Dry Bulk Carriers, aggregating 3.24 million dwt.
Fleet Expansion
The new Suezmax Tanker is scheduled for delivery in the second half of FY 2028-29. The vessel will be financed from internal accruals. This acquisition aims to further enhance the company’s capacity utilization, which is currently close to 100%. Moreover, GESHIP has contracted to buy two secondhand Kamsarmax Dry Bulk Carriers, expected to be completed in Q3 FY27.
Strategic Growth
This strategic move will bolster GESHIP’s fleet expansion plans and position the company for future growth. The company’s current capacity utilization is near maximum, and the new tanker will provide additional operational flexibility and revenue opportunities. As a result, GESHIP continues to strengthen its market presence and competitive edge in the global shipping industry.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of The Great Eastern Shipping Company Limited
The Great Eastern Shipping Company Limited belongs to the Industrials › Marine Shipping sector. Here’s a quick read on where the business and the stock stand today.
The holds in the upper half of its 52-week range, a sign the market backs the stock. D/E of 0.00 and a 3.85% dividend yield give the balance sheet a decent cushion. Industry-leading margins of 60.3% reflect exceptional pricing power and operational efficiency. RSI hits 71, a level that signals the stock runs hot. Notably, buyers drove volume on 18 recent sessions — though at these levels, some profit-taking is normal. The stock rises 3.4% in three months on -1.6% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of The Great Eastern Shipping Company Limited.
Industrials
Servotech Renewable Power System Limited Unveils Next-generation Solar Inverters at Navaarambh 2026
Servotech Renewable Power System Limited (SERVOTECH) unveils next-gen solar inverters and celebrates partnerships at Navaarambh 2026.
Servotech Renewable Power System Limited (NSE: SERVOTECH), India’s leading manufacturer of solar and renewable energy solutions, hosted ‘Navaarambh 2026’, a special channel partner meet and product launch event. The event celebrated partnerships, recognized contributions, and unveiled the company’s latest innovations. This marked a new era for Servotech, reflecting its journey towards innovation, growth, and a cleaner energy future.
Celebrating Partnerships
The event brought together over 300 channel partners from across India. Servotech’s Global Brand Ambassador Sonu Sood, alongside Raman Bhatia, Managing Director, and Sarika Bhatia, Director Sales, presented certificates to channel partners who became members of the privilege program on the announcement day itself. This initiative celebrated the partnerships that drive Servotech’s growth.
Unveiling Next-Generation Solar Inverters
A key highlight of the evening was the unveiling of three new products: Sparkle Pro IP54 Hybrid Inverter, Sparkle Elite IP65 Hybrid Inverter, and Advanced Micro Grid Inverter. These new-generation inverter solutions represent Servotech’s focus on smarter energy management, enhanced performance, and evolving customer requirements, strengthening its journey towards a cleaner and more technology-driven future.
As a result, Servotech continues to play a pivotal role in developing India’s renewable energy and EV technology infrastructure, with a renewed commitment to its channel partners and a vision for a sustainable future.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Servotech Renewable Power System Limited
Servotech Renewable Power System Limited belongs to the Industrials › Electrical Equipment & Parts sector. Here’s a quick read on where the business and the stock stand today.
Servotech drops 28.1% over three months and trades near its 52-week lows. Thin margins at 5.0% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue grows at 34.1% and profits at 44.9% CAGR. Both numbers are exceptional. RSI stands at 25, well into oversold territory. Yet sellers still dominated on 21 of recent sessions versus 9 for buyers, so the pressure has not fully lifted. Revenue grows at 34.1% and profits at 44.9% CAGR, with D/E of 0.00. Meanwhile, the stock dips 28.1% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Servotech Renewable Power System Limited.
AEQUS
Aequs Limited Approves ₹650 Crore Equity Infusion Through Warrants
Aequs Limited (AEQUS) approves ₹650 crore equity infusion through warrants to fund aerospace and consumer capacity expansion.
Aequs Limited (AEQUS) has approved a preferential issue of up to 2,80,71,690 warrants, each convertible into one fully paid-up equity share of face value ₹10, to Mellwood Trustee Services Private Limited (Trustee of the Melligeri Private Family Foundation) (“Promoter”). This move aggregates to approximately ₹650 crore and is aimed at funding the company’s aerospace and consumer capacity expansion and supporting its borrowing program.
Significance of the Infusion
The proceeds from this infusion will fund capacity expansion across the aerospace and consumer businesses, including the development of the Hosur facility, investment in subsidiaries and joint ventures supporting that expansion, and general corporate purposes. The equity will also provide the base against which the company raises its term borrowings for the expansion. This infusion aligns the Promoter Group’s economic commitment with the company’s long-term growth plans and capital requirements.
Execution and Timeline
Of the total issue size of approximately ₹650 crore, ₹325 crore will be payable upfront upon allotment of the warrants, representing 50 per cent of the issue size, and twice the regulatory minimum. The balance will be payable upon exercise of the warrants. The warrants may be exercised within 18 months from the date of allotment. Conversion of warrants into equity shares, by making payment of balance consideration, shall take place on or before December 31, 2027. Promoter has undertaken to pay the balance consideration in full, irrespective of the market price of the company’s shares at the time of exercise.
An Extraordinary General Meeting is scheduled on Thursday, October 22, 2026, through video conferencing to seek shareholders’ approval. The detailed terms and conditions of the proposed issue, along with other relevant disclosures, will be made available to shareholders and filed with the stock exchanges in accordance with applicable laws and regulations.
Aravind Melligeri, Executive Chairman & CEO, Aequs Limited, said: “We are winning programmes faster than we had planned for, and those wins need investment ahead of the revenue they bring. This issue gives Aequs committed capital to build that capacity and the equity base to support the borrowing that goes with it. The Promoter Group is subscribing at the price as per SEBI pricing formula and paying half of it upfront — that is the measure of our confidence in what this business can deliver.”
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Aequs Limited
Aequs Limited belongs to the Industrials › Aerospace & Defense sector. Here’s a quick read on where the business and the stock stand today.
Aequs posts a 7.5% three-month gain, but softens in the last few weeks. Margins at 12.4% are middling — adequate but leaving the business with little buffer against cost shocks. 4 loss quarters over five years is a serious red flag — earnings quality is poor and recovery is not guaranteed. The stock gives back 2.2% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. The stock holds up despite 14.8% revenue growth and a PEG of 99.00. That could signal an early turnaround. Alternatively, index flows simply support the price. Watch whether analysts revise estimates upward — that is the real signal. Check Fundamentals of Aequs Limited.
-
Beverages - Brewers3 days agoSom Distilleries & Breweries Limited (sdbl): Court Judgment Clears Path for Licence Renewal
-
Healthcare1 day agoLupin Limited (lupin) Receives Tentative FDA Approval for Apixaban Oral Suspension
-
Consumer Defensive1 day agoRadico Khaitan Limited Expands Global Reach: Indian Luxury Whisky Brands Land in the Home of Scotch
-
RATEGAIN1 day agoRategain Travel Technologies Limited (NSE: Rategain) Appoints Chetan Garg as Chief Financial Officer
-
Credit Services1 day agoMoneyboxx Finance Limited (moneyboxx) Raises ₹60 Crore Via Ncds
-
Healthcare1 day agoSun Pharmaceutical Industries Limited (sunpharma) Secures Global Licensing for Lerodalcibep, a PCSK9 Inhibitor
-
Capital Markets1 day agoIndian Energy Exchange Limited Expands Energy Markets Footprint
-
Healthcare1 day agoMorepen Laboratories Limited Submits First U.S. ANDA for Sitagliptin Tablets
